<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8606714</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4754</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Child Neurol.</journal-id>
<journal-title-group>
<journal-title>Journal of child neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29129154</article-id>
<article-id pub-id-type="pmc">5773119</article-id>
<article-id pub-id-type="doi">10.1177/0883073817737446</article-id>
<article-id pub-id-type="manuscript">NIHMS909782</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Predictors of drug-resistant epilepsy in tuberous sclerosis
complex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jeong</surname>
<given-names>Anna</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>Jo Anne</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>Michael</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Neurology, Washington University School of Medicine,
St. Louis, MO 63110</aff>
<aff id="A2">
<label>2</label>Tuberous Sclerosis Alliance, Silver Spring, MD</aff>
<aff id="A3">
<label>3</label>Hope Center for Neurological Disorders, Washington University School
of Medicine, St. Louis, MO 63110</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Current Address and Corresponding author: Anna Jeong,
MD, Epilepsy Center, Ann and Robert H. Lurie Children’s Hospital,
Mailing Address: 225 East Chicago Avenue, Box 29, Chicago, IL 60611, Phone:
312-227-3540, Fax: 312-227-9644,
<email>ajeong@luriechildrens.org</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>Declaration of Conflicting Interests</p>
<p>The authors declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>32</volume>
<issue>14</issue>
<fpage>1092</fpage>
<lpage>1098</lpage>
<!--elocation-id from pubmed: 10.1177/0883073817737446-->
<abstract>
<p id="P1">Utilizing the multicenter Tuberous Sclerosis Complex (TSC) Natural
History Database including 2034 subjects, this study aimed to identify
predictors of drug-resistant epilepsy in TSC. Basic epilepsy data were available
for 1965 individuals in the database. Supplemental data were further collected
from 1546 of these subjects through directed site queries, addressing additional
epilepsy characteristics including the presence of drug-resistant epilepsy,
therapies trialed, and outcomes of specific therapies. Epilepsy was reported in
86.4% of individuals with TSC. Infantile spasms were reported in
45.2% of individuals and focal seizures were reported in 84.4%
of individuals. In those with focal epilepsy, drug-resistance was reported in
59.6%, with focal seizure onset prior to age 1 year (OR 1.9, CI
1.4–2.5, p&lt;0.001), infantile spasms (OR 2.0, CI 1.5–2.5,
p&lt;0.001), and infantile spasms incompletely responsive to therapy (OR 47.6,
CI 6.7–333.3, p&lt;0.001) being associated with an increased likelihood
of drug-resistance.</p>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>tuberous sclerosis complex</kwd>
<kwd>refractory</kwd>
<kwd>infantile spasms</kwd>
<kwd>seizures</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>